|
|
| Research article summary (published 30 Mar 1993): |
Gianturco self-expanding stent in the treatment of stenosis in dialysis access grafts.
Full Abstract
This study evaluated the effectiveness of the Gianturco endovascular stent in preserving graft patency following percutaneous transvenous angioplasty (PTVA) of stenotic lesions occurring at the graft-vein anastomosis in hemodialysis patients with polytetrafluoroethylene grafts. Fifty-eight patients having 50% or greater stenosis were randomly divided into a treatment group (N = 28) and a concurrent control group (N = 30) following PTVA. In the treatment group, a stent was placed following dilatation. Graft thrombosis, the need for surgical revision, or the need for a repeat PTVA were used as end point events. The period of time from the PTVA/stent procedure to the end point event was referred to as the duration of efficacy (DE). By life table analysis, the DE for the treatment group was 100% at 30 days, 91% at 60 days, 85% at 90 days, 72% at 180 days, and 17% at 360 days. Comparison of the characteristics and results obtained in the treatment group and that of the concurrent control group revealed no significant difference in any parameter prior to treatment, in the response to PTVA, or in the DE of the procedure performed. It was concluded that the stent offered no advantage in the treatment of the graft-vein anastomosis stenotic lesion affecting PTFE dialysis access grafts.
Author information
Author/s: Beathard, G A (GA);
Affiliation: Austin Diagnostic Clinic, Texas.
Journal and publication information
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal: Kidney international (Kidney Int), published in UNITED STATES. (Language: eng)
Reference: 1993-Apr; vol 43 (issue 4) : pp 872-7
Dates: Created 1993/05/27; Completed 1993/05/27; Revised 2006/11/15;
PMID: 8479123, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Polytetrafluoroethylene (9002-84-0)Related articles
These are the most related articles currently in our database:
- Impact of reintervention for failing upper-extremity arteriovenous autogenous access for hemodialysis.
29 Nov 2001 - Equivalent secondary patency rates of upper extremity Vectra Vascular Access Grafts and transposed brachial-basilic fistulas with aggressive access surveillance and endovascular treatment.
24 Dec 2007 - Use of stents and stent grafts to salvage angioplasty failures in patients with hemodialysis grafts.
30 Dec 2007 - Management of thrombosed dialysis access: thrombectomy versus thrombolysis.
28 Feb 2004 - Vascular access stenosis: comparison of arteriovenous grafts and fistulas.
30 Oct 2004 - Prolongation of hemodialysis access survival with elective revision.
30 Oct 1995 - A new mechanical device for declotting of hemodialysis access grafts: first clinical experience.
30 Mar 2005 - Persistent left superior vena cava: diagnosis and implications for the interventional nephrologist.
30 Oct 2006 - Stenosis at the area of transposition - an under-recognized complication of transposed brachiobasilic fistulas.
29 Sep 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.